Doxycycline hyclate 100 MG oral tablets

Active Awarded Last action

Contract number
75A50325F80009
Awardee
Awarding agency
Obligated
$144,579,702

Award facts

Contract value 86% obligated
  • $144,579,701.76 Current, with exercised options
  • $167,964,526.08 Potential, with all options
Completion date 33% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Congers, NY 10920, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00003 · Exercise option ordering period year 3 - doxycycline hyclate 100 MG oral tablets $45,895,450
Supplemental Agreement for work within scope P00002 · Modification to update the period of performance on ordering period 2. $0
Exercise an Option P00001 · Exercise optional ordering period year 2 doxycycline hyclate 100 MG oral tablets $57,669,980
Original award $41,014,272

About this award

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response issued a delivery order to Chartwell RX LLC on June 23, 2025, for doxycycline hyclate 100 mg oral tablets under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule, with a ceiling value of $167.96 million and ultimate completion on June 22, 2029. The order is a firm fixed-price delivery under the Total Small Business set-aside and exercises Year 3 of an option ordering period.

Place of performance is Congers, NY. Chartwell RX is a pharmaceutical manufacturer and distributor supplying branded and generic medications to federal agencies as a prime contractor.

Quick answers

Who was awarded contract 75A50325F80009?

75A50325F80009 was awarded to Chartwell RX LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on June 23, 2025.

How much is contract 75A50325F80009 worth?

The government has obligated $144,579,702 on 75A50325F80009. Its potential value, with all options, is $167,964,526.

Is contract 75A50325F80009 an order under another contract?

Yes. 75A50325F80009 is a delivery order under 36F79720D0198, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75A50325F80009 competed?

The extent of competition for 75A50325F80009 was full and open competition. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award